Derm SAQs ·
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. — SAQ
On this page
Study tools
Prompt
Write your answer
Saved on this device. No marking — you are the marker.
Stem
A patient presents with features suggestive of pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.. Topical calcineurin inhibitors (TCIs: tacrolimus 0.03/0.1% ointment, pimecrolimus 1% cream) are non-steroid anti-inflammatory agents that inhibit calcineurin (a calcium/calmodulin-dependent phosphatas...
Questions
a) What is the most likely diagnosis and what clinical features support it? (2 marks)
b) What investigations would you arrange to confirm the diagnosis? (3 marks)
c) Outline your management plan for this patient. (3 marks)
d) What are the key complications and prognostic factors? (2 marks)